DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $704,000 | +316.6% | 175,929 | +409.4% | 0.00% | – |
| Q3 2019 | $169,000 | -1.2% | 34,538 | +22.7% | 0.00% | – |
| Q2 2019 | $171,000 | -48.6% | 28,158 | +63.9% | 0.00% | – |
| Q3 2018 | $333,000 | -26.7% | 17,181 | -3.4% | 0.00% | -100.0% |
| Q2 2018 | $454,000 | -17.0% | 17,781 | -34.5% | 0.00% | 0.0% |
| Q1 2018 | $547,000 | +3.4% | 27,144 | +43.6% | 0.00% | 0.0% |
| Q3 2016 | $529,000 | -22.9% | 18,900 | -3.6% | 0.00% | 0.0% |
| Q2 2016 | $686,000 | +175.5% | 19,600 | +115.4% | 0.00% | – |
| Q1 2016 | $249,000 | -25.0% | 9,100 | -6.2% | 0.00% | -100.0% |
| Q4 2015 | $332,000 | +19.0% | 9,700 | 0.0% | 0.00% | – |
| Q3 2015 | $279,000 | -37.7% | 9,700 | -3.0% | 0.00% | -100.0% |
| Q2 2015 | $448,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |